QRL-204

N/A

Report date: 2025/12/08 17:13:53

Base Information

Drug NameQRL-204
Drug Alias NameQRL-204
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUnc-13 Homolog A stimulants
TargetsUnc-13 Homolog A
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesQurAlis Corp
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyQurAlis Corp
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A